Matinas BioPharma | Investor Presentation Deck | 31 slides · page 26 of 31
The chart shows a clear dose-response relationship with increasing efficacy of the LNC formulation at 2.5, 5, and 10 nM doses.
Pitch deck · traction · show_traction · dense density
Slide locked Sign in to view
Slide schematic 5/5
chart 1/1 list 1/1 title 3/3
Components 5
bar-grouped bullet headline headline headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.